F. Ostronic
Direttore/Membro del Consiglio presso CYCLO THERAPEUTICS, INC.
Patrimonio netto: 446 427 $ in data 31/05/2024
Posizioni attive di F. Ostronic
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| CYCLO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 09/04/2014 | - |
| Independent Dir/Board Member | 09/04/2014 | - | |
| The Usp Group, Inc. | Direttore Finanziario/CFO | - | - |
| Novit US, Inc. | Direttore/Membro del Consiglio | - | - |
| Novit LP | Corporate Officer/Principal | - | - |
Storia della carriera di F. Ostronic
Precedenti posizioni note di F. Ostronic
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Direttore/Membro del Consiglio | 05/02/2013 | - |
Formazione di F. Ostronic
| College of the Holy Cross (Massachusetts) | Undergraduate Degree |
| Old Dominion University | Graduate Degree |
| The University of Maryland Francis King Carey School of Law | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 9 |
Posizioni
| Director/Board Member | 3 |
| Graduate Degree | 2 |
| Independent Dir/Board Member | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| CYCLO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Tamir Biotechnology, Inc. engages in the discovering and developing of new class therapeutic drugs for the treatment of cancer and other pathological conditions. The firm's proprietary drug discovery program is also the basis for the development of recombinant designed RNases for chemical conjugation and fusion products with various targeting moieties, such as monoclonal antibodies, growth factors, and cytokines. The company was founded on August 24, 1981 and is headquartered in Short Hills, NJ. | Health Technology |
| The Usp Group, Inc. | |
| Novit US, Inc. | |
| Novit LP |
- Borsa valori
- Insiders
- F. Ostronic
- Esperienza
